Hormonal contraceptive use and risk of HIV-1 disease progression - Wikidata - awgldk - TriplyDB

Hormonal contraceptive use and risk of HIV-1 disease progression

Hormonal contraceptive use and risk of HIV-1 disease progression

http://www.wikidata.org/entity/Q37088950

about

Beyond the Pap Smear: Gender-responsive HIV Care for Women What's new for antiretroviral treatment in women with HIV Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion 17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha.Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures.Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women.Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries.Factors associated with discussion of sexual activity and contraception in women with HIV.Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: A Systematic review.Misreporting of contraceptive hormone use in clinical research participants.Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.

P2860

Q26746179-453B1020-26EB-4830-A327-F497F5160AF9 Q30391322-A0F8D82F-18B4-481E-A584-F0BE1A96BDDF Q33595754-F61798B6-C401-46AF-A3DE-2433951E06CF Q33631612-2B3B7DB2-D44F-4136-A20A-3D094E4924F1 Q34538556-AD6B3E86-F6CB-4F8C-9D08-F7EEB4449C6E Q34673931-3737A367-4A57-4A36-8DF5-F707C6F6DDB0 Q36395963-E0A55793-4533-4BC9-84B9-3D0514BA74AF Q36576629-E58D5012-326F-439F-AF56-CEC5BBAA4445 Q37619260-0654BE4F-A08A-4342-984C-8ADB01E80585 Q41031435-A210C1D7-EAE4-4BBC-8102-B292CEE214C8 Q41694386-D6654823-8B7E-4023-BC2D-9F82E3743B01 Q46010525-4534653B-1638-4A39-83E0-A81EC41282C9 Q52561199-51763C26-03DC-4AA9-95A7-09C11B6373E1

P2860

Hormonal contraceptive use and risk of HIV-1 disease progression

http://www.wikidata.org/entity/Q37088950

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hormonal contraceptive use and risk of HIV-1 disease progression

@en

Hormonal contraceptive use and risk of HIV-1 disease progression.

@nl

type

label

Hormonal contraceptive use and risk of HIV-1 disease progression

@en

Hormonal contraceptive use and risk of HIV-1 disease progression.

@nl

prefLabel

Hormonal contraceptive use and risk of HIV-1 disease progression

@en

Hormonal contraceptive use and risk of HIV-1 disease progression.

@nl

P1433

Q37088950-DD90670D-87F7-46BA-9448-CBB65793E328

P1476

Q37088950-549819E6-04A8-4723-89E2-D9FA68931491

P2093

Q37088950-233C5D8B-0C25-4E34-BC6C-6E1D4954FD31

Q37088950-40CEAF59-C9DE-408C-A88F-9895659EB7F7

Q37088950-57403081-6928-456B-9860-533EA7F6F711

Q37088950-6AD46CFC-F668-4A9E-9FDC-CC1D5EA0A67D

Q37088950-A1B9FD3B-0A0F-4858-B916-CE2ABD76D125

Q37088950-A6676C40-18EC-428E-9887-15236CA34E57

Q37088950-B93F7ECE-595E-43A0-B0FB-85630D05096D

Q37088950-F5A1D2AC-3CA7-4996-B545-A8896A953996

P2860

Q37088950-4C10E42E-16A9-42E2-845F-C2CDC2D167B8

Q37088950-4D3A7A0B-C204-4A84-A87E-BC5F14C3D6B1

Q37088950-5966C4FC-B38D-41F7-AE7B-C1762A0F3AE5

Q37088950-5F922B2E-BC13-4093-BB25-38EB9189F44D

Q37088950-6E63FE00-274C-4988-9598-BD6A7B768128

Q37088950-727D67F4-14CA-4789-9A2D-79913797CD5B

Q37088950-8423C247-21C5-4490-ACB8-1DA2DB97F42E

Q37088950-87BD7D08-6086-4BFD-BC3C-20B894B41501

Q37088950-8E24AECD-4AF9-458F-8BD4-93D07697700A

Q37088950-9410020D-63A5-48E1-B1AF-9464514A9466

P304

Q37088950-D86E3285-B839-4111-B687-B629BAE45F4F

P31

Q37088950-253FA9A2-581B-4D93-BABE-5D14A43585BD

P356

Q37088950-D9519043-ABB6-4AC7-B775-0EBF8BC354A6

P407

Q37088950-305F4560-C138-494D-952B-32270FA7C734

P433

Q37088950-DAA19E81-46B0-46CF-B4BA-9E5B2CF1AABE

P478

Q37088950-DD1CB44F-482F-4F87-A0BE-7A8C31A01634

P50

Q37088950-8E86D6AA-0A3D-4CC3-B171-EDEDEA9A21CC

Q37088950-C1C1DAF1-E64D-42F6-B372-24ACC6F259C4

Q37088950-D473020C-4C73-4F3C-B5A4-B59EBCE91D3F

Q37088950-D89BDD4F-F37E-43B4-BFD6-110F7F63927D

P577

Q37088950-C3DFB08B-7035-452D-9F5F-F0786C6B4B65

P698

Q37088950-D1EC7AAB-86B9-4267-8472-78BA264DAE0F

P921

Q37088950-53E8FE31-5999-43C0-8413-5612F27E8766

P932

Q37088950-4F4F4B47-4D50-4E65-818F-092FE239536E

P356

QAD.0B013E32835AD473

P1433

P1476

Hormonal contraceptive use and risk of HIV-1 disease progression

@en

P2093

Edwin Were

http://www.w3.org/2001/XMLSchema#string

Helen Rees

http://www.w3.org/2001/XMLSchema#string

James Kiarie

http://www.w3.org/2001/XMLSchema#string

Jared M Baeten

http://www.w3.org/2001/XMLSchema#string

Kenneth Ngure

http://www.w3.org/2001/XMLSchema#string

Nelly Mugo

http://www.w3.org/2001/XMLSchema#string

Partners in Prevention HSVHIV Transmission Study Team

http://www.w3.org/2001/XMLSchema#string

Renee Heffron

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of HIV-1 infection with early antiretroviral therapy

Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.

Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population.

Pharmacokinetics of depot medroxyprogesterone acetate contraception.

HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial

Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

P304

261-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32835AD473

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Deborah Donnell

Partners in Prevention HSV/HIV Transmission Study Team

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23079806

http://www.w3.org/2001/XMLSchema#string

P921

P932

3740957

http://www.w3.org/2001/XMLSchema#string